Ocean Biomedical Stock Current Valuation
| OCEA Stock | 0.71 0.02 2.90% |
Valuation analysis of Ocean Biomedical helps investors to measure Ocean Biomedical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. As of November 21, 2024, Enterprise Value Over EBITDA is expected to decline to -376.31. In addition to that, Enterprise Value Multiple is expected to decline to -376.31. Fundamental drivers impacting Ocean Biomedical's valuation include:
Price Book 100.6724 | Enterprise Value 35.9 M | Enterprise Value Ebitda (9.48) |
Undervalued
Today
Please note that Ocean Biomedical's price fluctuation is unstable at this time. Calculation of the real value of Ocean Biomedical is based on 3 months time horizon. Increasing Ocean Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Ocean Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Ocean Stock. However, Ocean Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.71 | Real 4.87 | Target 17.45 | Hype 0.7 | Naive 0.7 |
The real value of Ocean Stock, also known as its intrinsic value, is the underlying worth of Ocean Biomedical Company, which is reflected in its stock price. It is based on Ocean Biomedical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Ocean Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Ocean Biomedical helps investors to forecast how Ocean stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Ocean Biomedical more accurately as focusing exclusively on Ocean Biomedical's fundamentals will not take into account other important factors: Ocean Biomedical Company Current Valuation Analysis
Ocean Biomedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Ocean Biomedical Current Valuation | 35.93 M |
Most of Ocean Biomedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ocean Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ocean Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Ocean Biomedical is extremely important. It helps to project a fair market value of Ocean Stock properly, considering its historical fundamentals such as Current Valuation. Since Ocean Biomedical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ocean Biomedical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ocean Biomedical's interrelated accounts and indicators.
Click cells to compare fundamentals
Ocean Current Valuation Historical Pattern
Today, most investors in Ocean Biomedical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Ocean Biomedical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Ocean Biomedical current valuation as a starting point in their analysis.
Ocean Biomedical Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Ocean Biomedical has a Current Valuation of 35.93 M. This is 99.75% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all United States stocks is 99.78% higher than that of the company.
Ocean Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ocean Biomedical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ocean Biomedical could also be used in its relative valuation, which is a method of valuing Ocean Biomedical by comparing valuation metrics of similar companies.Ocean Biomedical is currently under evaluation in current valuation category among its peers.
Ocean Fundamentals
| Return On Asset | -6.82 | ||||
| Current Valuation | 35.93 M | ||||
| Shares Outstanding | 34.65 M | ||||
| Shares Owned By Insiders | 71.98 % | ||||
| Shares Owned By Institutions | 11.62 % | ||||
| Number Of Shares Shorted | 165.46 K | ||||
| Price To Book | 100.67 X | ||||
| EBITDA | (957.74 K) | ||||
| Net Income | (958.43 K) | ||||
| Total Debt | 2.15 M | ||||
| Book Value Per Share | (2.21) X | ||||
| Cash Flow From Operations | (747.3 K) | ||||
| Short Ratio | 2.64 X | ||||
| Earnings Per Share | (3.00) X | ||||
| Target Price | 18.5 | ||||
| Beta | 1.53 | ||||
| Market Capitalization | 25.64 M | ||||
| Total Asset | 110.91 M | ||||
| Retained Earnings | (2.77 M) | ||||
| Working Capital | (3 M) | ||||
| Net Asset | 110.91 M |
About Ocean Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ocean Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ocean Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ocean Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ocean Biomedical is a strong investment it is important to analyze Ocean Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ocean Biomedical's future performance. For an informed investment choice regarding Ocean Stock, refer to the following important reports:Check out Ocean Biomedical Piotroski F Score and Ocean Biomedical Altman Z Score analysis. For information on how to trade Ocean Stock refer to our How to Trade Ocean Stock guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocean Biomedical. If investors know Ocean will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocean Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.00) | Return On Assets (6.82) |
The market value of Ocean Biomedical is measured differently than its book value, which is the value of Ocean that is recorded on the company's balance sheet. Investors also form their own opinion of Ocean Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Ocean Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocean Biomedical's market value can be influenced by many factors that don't directly affect Ocean Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocean Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocean Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocean Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.